Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Obesity01:24

Obesity

1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

412
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
412
Depression: Overview01:18

Depression: Overview

747
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
747

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Maternal pre-pregnancy BMI differentially regulates intracellular pH in human umbilical vein endothelium from gestational diabetes mellitus pregnancies, with alkalinisation-associated reduction of adenosine transport in normal weight pregnancies.

Diabetologia·2026
Same author

Maresins.

Biomolecules·2026
Same author

The Role of Dandelion (<i>Taraxacum officinale</i>) in Liver Health and Hepatoprotective Properties.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Shortcomings, limitations and gaps in physiological roles of extracellular vesicles in obesity.

The Journal of physiology·2024
Same author

<i>Azorella compacta</i> Organic Extracts Exacerbate Metabolic Dysfunction-Associated Fatty Liver Disease in Mice Fed a High-Fat Diet.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Adipose Tissue, Non-Communicable Diseases, and Physical Exercise: An Imperfect Triangle.

International journal of molecular sciences·2023

相关实验视频

Updated: Jan 9, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

449

肥胖和抑郁症:一种病理生理毒性关系

Francisco A Monsalve1, Barbra Fernández-Tapia2, Oscar C Arriagada1

  • 1Department of Preclinical Sciences, Faculty of Medicine, Universidad Católica del Maule, Talca 3466706, Chile.

International journal of molecular sciences
|December 11, 2025
PubMed
概括
此摘要是机器生成的。

肥胖和严重抑郁症有着共同的生物学途径,包括炎症,神经内分泌,代谢和肠道-大脑干扰. 了解这些联系对于综合治疗策略至关重要.

关键词:
在HPA轴上.抑郁 抑郁症 抑郁症 抑郁症 抑郁症这是一种炎症炎症炎症炎症.代谢功能障碍 代谢功能障碍肠道微生物大脑轴神经炎症是一种神经炎症.肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖

更多相关视频

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.3K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

875

相关实验视频

Last Updated: Jan 9, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

449
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.3K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

875

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 代谢障碍 代谢障碍 代谢障碍

背景情况:

  • 肥胖和严重抑郁症 (MDD) 是全球普遍存在的疾病,其发病率正在增加.
  • 流行病学和分子证据表明,它们的基础生物学存在显著的重叠.

研究的目的:

  • 审查和综合当前关于肥胖和MDD的共享流行病学和病理生理学的证据.
  • 强调融合机制,包括炎症,神经内分泌,代谢,遗传和肠-大脑轴.

主要方法:

  • 现有流行病学和分子研究的叙述性审查.
  • 综合证据的双向路径链接肥胖和抑郁症.

主要成果:

  • 共同的途径包括慢性低度炎症,下丘脑-垂体-上腺 (HPA) 轴失调,代谢和神经营养信号缺陷,脂质衍生的神经毒性和肠-大脑轴扰乱.
  • 这些机制有助于神经炎症和情绪失调在患有肥胖的人.

结论:

  • 需要综合管理策略来解决肥胖和MDD之间的相互作用.
  • 未来的研究应该集中在共享的生物标志物和个性化干预措施使用多omics和系统医学.